Sign in

    Jonathan Jeff • Baird

    No publicly available information could be found to confirm the existence of Jonathan Jeff as an analyst at Baird or to provide details regarding his career, performance, company coverage, or credentials. Comprehensive research yielded no professional profiles, LinkedIn pages, or authoritative mentions linking Jonathan Jeff to Baird's research or analyst teams. As a result, a detailed professional profile meeting the requested criteria cannot be provided at this time.

    Jonathan Jeff's questions to Beta Bionics Inc (BBNX) leadership

    Jonathan Jeff's questions to Beta Bionics Inc (BBNX) leadership • Q1 2025

    Question

    Jonathan Jeff asked about early indications of patient attrition rates, noting that pump supply revenue appeared stronger than expected, which might suggest lower attrition.

    Answer

    CFO Stephen Feider declined to provide specific attrition rate figures for competitive reasons. However, he emphasized that the company's confidence in the pharmacy channel's long-term value is based on their internal data on retention, implying that attrition rates are favorable and support their financial models.

    Ask Fintool Equity Research AI